Gellan Sulfate Core Platinum Coil with Tenascin-C Promotes Intra-Aneurysmal Organization in Rats

Translational Stroke Research

Volumn 5, Issue 5, 2014, Pages 595-603

  Hamada, Kazuhide ^a   Miura, Yoichi ^a   Toma, Naoki ^a   Miyamoto, Keiichi ^b   Imanaka Yoshida, Kyoko ^a   Matsushima, Satoshi ^a   Yoshida, Toshimichi ^a   Taki, Waro ^a   Suzuki, Hidenori ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY   (Japan)

Author keywords

Coil embolization; Gellan sulfate; Rat; Tenascin C

Indexed keywords

GELLAN; GELLAN SULFATE CORE PLATINUM COIL; PLATINUM; TENASCIN; UNCLASSIFIED DRUG; GELLAN SULFATE; POLYSACCHARIDE; SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ARTERY ANEURYSM; COIL EMBOLIZATION; COMMON CAROTID ARTERY; CONTROLLED STUDY; DRUG ADSORPTION; DRUG EFFECT; FOLLOW UP; GLIOMA CELL LINE; IN VITRO STUDY; IN VIVO STUDY; ION EXCHANGE CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TIME; ANIMAL; ARTIFICIAL EMBOLISM; DEVICES; DISEASE MODEL; INTRACRANIAL ANEURYSM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; DISEASE MODELS, ANIMAL; EMBOLIZATION, THERAPEUTIC; INTRACRANIAL ANEURYSM; MALE; PLATINUM; POLYSACCHARIDES; RATS; RATS, SPRAGUE-DAWLEY; SULFURIC ACID ESTERS; TENASCIN;

EID: 84905588955     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-014-0352-z     Document Type: Article

References (29)

1. Connolly Jr ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43: 1711-37.
2. Bavinzski G, Talazoglu V, Killer M, Richling B, Gruber A, Gross CE, et al. Gross and microscopic histopathological findings in aneurysms of the human brain treated with Guglielmi detachable coils. J Neurosurg. 1999;91: 284-93.
3. Szikora I, Seifert P, Hanzely Z, Kulcsar Z, Berentei Z, Morosfoi M, et al. Histopathologic evaluation of aneurysms treated with Guglielmi detachable coils or matrix detachable microcoils. AJNR Am J Neuroradiol. 2006;27: 283-8.
4. Toma N, Imanaka-Yoshida K, Takeuchi T, Matsushima S, Iwata H, Yoshida T, et al. Tenascin-C-coated platinum coils for acceleration of organization of cavities and reduction of lumen size in a rat aneurysm model. J Neurosurg. 2005;103: 681-6.
5. Midwood KS, Orend G. The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal. 2009;3: 287-310.
6. Miyamoto K, Asakawa Y, Arai Y, Shimizu T, Tokita M, Komai T. Preparation of gellan sulfate as an artificial ligand for removal of extra domain A containing fibronectin. Int J Biol Macromol. 2001;28: 381-5.
7. Yoshida T, Yoshimura E, Numata H, Sakakura Y, Sakakura T. Involvement of tenascin-C in proliferation and migration of laryngeal carcinoma cells. Virchows Arch. 1999;435: 496-500.
8. Miyamoto K, Sugihara K, Abe Y, Nobori T, Tokita M, Komai T. Novel plasma-separation dilayer gellan-gellan-sulfate adsorber for direct removal of extra domain A containing fibronectin from the blood of rheumatoid arthritis patients. Int J Biol Macromol. 2002;30: 197-204.
9. Scatchard G. The attractions of proteins for small molecules and ions. Ann NY Acad Sci. 1949;51: 660-72.
10. Abrahams JM, Forman MS, Grady MS, Diamond SL. Delivery of human vascular endothelial growth factor with platinum coils enhances wall thickening and coil impregnation in a rat aneurysm model. AJNR Am J Neuroradiol. 2001;22: 1410-7.
11. Murayama Y, Vinuela F, Ishii A, Nien YL, Yuki I, Duckwiler G, et al. Initial clinical experience with matrix detachable coils for the treatment of intracranial aneurysms. J Neurosurg. 2006;105: 192-9.
12. Taschner CA, Leclerc X, Rachdi H, Barros AM, Pruvo JP. Matrix detachable coils for the endovascular treatment of intracranial aneurysms: analysis of early angiographic and clinical outcomes. Stroke. 2005;36: 2176-80.
13. Ansari SA, Dueweke EJ, Kanaan Y, Chaudhary N, Gandhi D, Thompson BG, et al. Embolization of intracranial aneurysms with second-generation Matrix-2 detachable coils: mid-term and long-term results. J Neurointerv Surg. 2011;3: 324-30.
14. Ohyama T, Nishide T, Iwata H, Sato H, Toda M, Taki W. Vascular endothelial growth factor immobilized on platinum microcoils for the treatment of intracranial aneurysms: experimental rat model study. Neurol Med Chir (Tokyo). 2004;44: 279-87.
15. Sano H, Toda M, Sugihara T, Uchiyama N, Hamada J, Iwata H. Coils coated with the cyclic peptide SEK-1005 accelerate intra-aneurysmal organization. Neurosurgery. 2010;67: 984-92.
16. Matsumoto H, Terada T, Tsuura M, Itakura T, Ogawa A. Basic fibroblast growth factor released from a platinum coil with a poly-vinyl alcohol core enhances cellular proliferation and vascular wall thickness: an in vitro and in vivo study. Neurosurgery. 2003;53: 402-8.
17. Tsumoto T, Matsumoto H, Terada T, Tsuura M, Itakura T, Hamamoto T. A polyvinyl alcohol core coil containing basic fibroblast growth factor evaluated in rabbits with aneurysms induced by elastase. Neurosurgery. 2007;61: 160-6.
18. Brathwaite S, Macdonald RL. Current management of delayed cerebral ischemia: update from results of recent clinical trials. Transl Stroke Res. 2014;5: 207-26.
19. Shiba M, Fujimoto M, Imanaka-Yoshida K, Yoshida T, Taki W, Suzuki H. Tenascin-C causes neuronal apoptosis after subarachnoid hemorrhage in rats. Transl Stroke Res. 2014;5: 238-47.
20. Jones PL, Jones FS. Tenascin-C in development and disease: gene regulation and cell function. Matrix Biol. 2000;19: 581-96.
21. El-Karef A, Yoshida T, Gabazza EC, Nishioka T, Inada H, Sakakura T, et al. Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice. J Pathol. 2007;211: 86-94.
22. Nishioka T, Suzuki M, Onishi K, Takakura N, Inada H, Yoshida T, et al. Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: involvement of tenascin-C induced by aldosterone-mediated inflammation. J Cardiovasc Pharmacol. 2007;49: 261-8.
23. Jones PL, Rabinovitch M. Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation. Circ Res. 1996;79: 1131-42.
24. Yamamoto K, Onoda K, Sawada Y, Fujinaga K, Imanaka-Yoshida K, Shimpo H, et al. Tenascin-C is an essential factor for neointimal hyperplasia after aortotomy in mice. Cardiovasc Res. 2005;65: 737-42.
25. Fujimoto M, Suzuki H, Shiba M, Shimojo N, Imanaka-Yoshida K, Yoshida T, et al. Tenascin-C induces prolonged constriction of cerebral arteries in rats. Neurobiol Dis. 2013;55: 104-9.
26. Kalembeyi I, Inada H, Nishiura R, Imanaka-Yoshida K, Sakakura T, Yoshida T. Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1. Int J Cancer. 2003;105: 53-60.
27. Sarker S, Nuttall RK, Liu S, Edwards DR, Yong VW. Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12. Cancer Res. 2006;66: 11771-80.
28. Wallner K, Li C, Shah PK, Wu KJ, Schwartz SM, Sharifi BG. EGF-like domain of tenascin-C is proapoptotic for cultured smooth muscle cells. Arterioscler Tromb Vasc Biol. 2004;24: 1416-21.
29. Jansson PE, Lindberg B, Sandford PA. Structural studies of gellan gum, an extracellular polysaccharide elaborated by Pseudomonas elodea. Carbohydr Res. 1983;124: 135-9.